Home Patent Forecast® Sectors Log In   Contact  
How it works Patent Forecast® Sectors Pricing Insights

Application US20220062237
Small Pharma

Injectable Formulation

Described herein are pharmaceutical formulations, methods for their production, and uses thereof. The pharmaceutical formulations comprise a salt of an optionally substituted dimethyltryptamine compound, a buffer, which is separate to the salt, and water. The formulations have pH values of from about 3.5 to about 6.5 and osmolalities of about 250 to about 350 mOsm/Kg. Such formulations are suitable for injection, being both stable and clinically acceptable, and have potential uses in the treatment of psychiatric or neurological disorders.

Much More than Average Length Specification

1 Independent Claims

View Abstract and Specification Size

PDF with Images and Document Face >

Full Text Publication >

Patent Matrix® Search

USPTO Patent Document Number